NBI-6024 exhibits potent antibacterial activity against a broad spectrum of pathogens, making it an effective therapeutic option. Through its mechanism of action, NBI-6024 targets specific pathways within bacterial cells, rendering them vulnerable and inhibiting their growth.
CAT No: R2037
CAS No:239480-61-6
Chemical Name:(4S)-4-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]acetyl]amino]-5-[[(2S)-1-(carboxymethylamino)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
NBI-6024 is a synthetic peptide compound designed to mimic specific antigenic epitopes relevant to immunological research. As a peptide-based molecule, it is engineered for high sequence specificity and stability, making it an important tool for investigators studying immune modulation, antigen presentation, and T-cell response mechanisms. The structural properties of NBI-6024 allow for precise interrogation of peptide-MHC (major histocompatibility complex) interactions, supporting its use in advanced immunology and cellular biology applications. Its functional relevance is underscored by its ability to model autoantigenic or disease-associated peptide sequences, enabling researchers to dissect complex immune recognition processes in a controlled laboratory setting.
Antigen-specific T-cell response studies: NBI-6024 serves as a valuable reagent for evaluating antigen-specific T-cell activation and proliferation in vitro. By presenting a defined peptide epitope, it allows researchers to investigate the specificity and magnitude of T-cell responses under controlled experimental conditions. This application is particularly relevant for dissecting mechanisms of immune tolerance, autoimmunity, and the functional properties of T-cell subsets in response to discrete peptide sequences.
Peptide-MHC binding assays: The compound is widely employed in assays designed to assess peptide affinity for various MHC class II molecules. By incorporating NBI-6024 into binding studies, scientists can quantitatively and qualitatively analyze peptide-MHC interactions, which are central to understanding antigen processing and presentation. Such assays facilitate the identification of immunodominant epitopes and contribute to mapping the molecular determinants of immune recognition.
Immunological tolerance modeling: NBI-6024 is instrumental in experimental models that seek to elucidate the mechanisms underlying immunological tolerance. By exposing immune cells to this synthetic peptide, researchers can simulate the presentation of self or altered self-antigens, providing insights into the cellular and molecular pathways that regulate tolerance induction, deletion, or anergy in T-cell populations. This approach is critical for advancing fundamental knowledge of immune self-regulation and the breakdown thereof.
Peptide-based assay development: The unique sequence characteristics and stability of NBI-6024 make it an excellent candidate for the development of peptide-based immunoassays. These assays are used to quantify antigen-specific immune responses, screen for peptide-reactive antibodies, or monitor immune modulation in various research models. The compound's well-defined structure ensures reproducibility and reliability in assay performance, supporting robust experimental outcomes.
Epitope mapping and structure-activity relationship studies: NBI-6024 is frequently utilized in systematic epitope mapping experiments to delineate the critical amino acid residues responsible for immune recognition. By comparing its activity with that of related peptide analogs, researchers can establish structure-activity relationships that inform the design of improved peptide reagents or immunological probes. This application provides a foundation for rational peptide engineering and the advancement of targeted immunological research tools.
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More